Cargando…

Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive neurodegenerative condition that is invariably fatal, usually within 3 to 5 years of diagnosis. The etiology of ALS remains unresolved and no effective treatments exist. There is therefore a desperate and unmet need for discovery of d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziff, Oliver J., Patani, Rickie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351881/ https://www.ncbi.nlm.nih.gov/pubmed/30565851 http://dx.doi.org/10.1111/acel.12862

Ejemplares similares

Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective
por: Pandya, Virenkumar A, et al.
Publicado: (2020)

The microglial component of amyotrophic lateral sclerosis
por: Clarke, Benjamin E, et al.
Publicado: (2020)

Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis
por: Tyzack, Giulia E, et al.
Publicado: (2021)

Astrocytes display cell autonomous and diverse early reactive states in familial amyotrophic lateral sclerosis
por: Taha, Doaa M, et al.
Publicado: (2022)

Experimental and Therapeutic Opportunities for Stem Cells in Multiple Sclerosis
por: Patani, Rickie, et al.
Publicado: (2012)

Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis
por: Smethurst, Phillip, et al.
Publicado: (2020)

Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis
por: Tyzack, Giulia E, et al.
Publicado: (2019)

288 Harnessing the potential of transcriptional adaptation as a mechanism for Amyotrophic lateral sclerosis
por: Gomez, Adriana Morales, et al.
Publicado: (2023)

Generating Diverse Spinal Motor Neuron Subtypes from Human Pluripotent Stem Cells
por: Patani, Rickie
Publicado: (2016)

Human stem cell-derived astrocytes exhibit region-specific heterogeneity in their secretory profiles
por: Clarke, Benjamin E, et al.
Publicado: (2020)

Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk Prediction
por: Pain, Oliver, et al.
Publicado: (2023)

Stem cell therapy for amyotrophic lateral sclerosis
por: Mao, Zhijuan, et al.
Publicado: (2015)

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
por: Rizzo, Federica, et al.
Publicado: (2013)

Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
por: Schirò, Giuseppe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis: applications of stem cells – an update
por: Cova, Lidia, et al.
Publicado: (2010)

Stress-Specific Spatiotemporal Responses of RNA-Binding Proteins in Human Stem Cell-Derived Motor Neurons
por: Harley, Jasmine, et al.
Publicado: (2020)

The translational potential of human induced pluripotent stem cells for clinical neurology: The translational potential of hiPSCs in neurology
por: Devine, Helen, et al.
Publicado: (2016)

Human Stem Cell-Derived Astrocytes: Specification and Relevance for Neurological Disorders
por: Tyzack, Giulia, et al.
Publicado: (2016)

Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states
por: Ziff, Oliver J., et al.
Publicado: (2022)

Taking Cellular Heterogeneity Into Consideration When Modeling Astrocyte Involvement in Amyotrophic Lateral Sclerosis Using Human Induced Pluripotent Stem Cells
por: Stifani, Stefano
Publicado: (2021)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Neural Conversion and Patterning of Human Pluripotent Stem Cells: A Developmental Perspective
por: Zirra, Alexandra, et al.
Publicado: (2016)

Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
por: Oh, Ki‐Wook, et al.
Publicado: (2018)

2219: Amyotrophic lateral sclerosis, stem cells and TALENted technology
por: Kurani, Shaheen, et al.
Publicado: (2018)

Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis
por: Lewis, Christina M, et al.
Publicado: (2014)

Case Report: Stem cell therapy in amyotrophic lateral sclerosis
por: Hassan, Ala'a A., et al.
Publicado: (2022)

Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis
por: Du, Hongmei, et al.
Publicado: (2023)

Glial Cells in Amyotrophic Lateral Sclerosis
por: Lasiene, Jurate, et al.
Publicado: (2011)

FUS is lost from nuclei and gained in neurites of motor neurons in a human stem cell model of VCP-related ALS
por: Harley, Jasmine, et al.
Publicado: (2020)

Human Neural Stem Cell Replacement Therapy for Amyotrophic Lateral Sclerosis by Spinal Transplantation
por: Hefferan, Michael P., et al.
Publicado: (2012)

Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications
por: Liu, Jia, et al.
Publicado: (2017)

Genetic Rodent Models of Amyotrophic Lateral Sclerosis
por: Van Den Bosch, L.
Publicado: (2011)

Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017)

Where and Why Modeling Amyotrophic Lateral Sclerosis
por: Liguori, Francesco, et al.
Publicado: (2021)

Staging model for amyotrophic lateral sclerosis in Singapore
por: Tay, Yuan Teck, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_02emh5cdhofv1fcm82ee4ggnt0